Parkinson David Ross 4
4 · ESSA Pharma Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Parkinson David Ross
DirectorPresident and CEO
Transactions
- Award
Options
2024-03-25+350,000→ 350,000 totalExercise: $9.04From: 2025-03-25Exp: 2034-03-25→ Common Shares (350,000 underlying)
Footnotes (1)
- [F1]Stock options vest and become exercisable over four years as follows: (i) 25% of the underlying shares vest one year after the grant date; and (ii) 75% of the remaining underlying shares vest in equal monthly installments over the following three years.